SCHEMBL6684693

SCHEMBL6684693

CONc1cc2ccccc2cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 2/20 0.49
CYP1A2 P05177 1/20 0.48
CYP2A6 P11509 1/20 0.48
EGFR P00533 1/20 0.47
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
NOTUM Q6P988 1/20 0.44
PDPK1 O15530 1/20 0.44
IGF1R P08069 1/20 0.44
MTOR P42345 1/20 0.41
PDGFRB P09619 2/20 0.39
PDGFRA P16234 2/20 0.39
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
TTK P33981 1/20 0.38
ABL1 P00519 1/20 0.38
KMT2A Q03164 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
HTR3A P46098 1/20 0.38
PDE10A Q9Y233 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13804176 0.78 CYP1A2 (0.54) CHEK1CYP1A2CYP2A6EGFRNPC1
Hydrochloric Acid SCHEMBL7398907 0.76 CYP1A2 (0.52) CHEK1CYP1A2CYP2A6EGFRNPC1
SCHEMBL12915410 0.74 CYP1A2 (0.50) CHEK1CYP1A2CYP2A6EGFRNPC1
SCHEMBL1922139 0.74 PDGFRB (0.56) CHEK1CYP1A2CYP2A6NPC1RAB9A
SCHEMBL25242404 0.74 PDPK1 (0.54) CHEK1CYP1A2CYP2A6EGFRNPC1
SCHEMBL3662977 0.74 CHEK1 (0.49) CHEK1CYP1A2CYP2A6EGFRNPC1
SCHEMBL14599973 0.73 CYP1A2 (0.48) CHEK1CYP1A2CYP2A6EGFRNPC1
SCHEMBL14185051 0.73 CYP1A2 (0.48) CHEK1CYP1A2CYP2A6EGFRNPC1
SCHEMBL28512102 0.73 USP30 (0.49) CHEK1CYP1A2CYP2A6EGFRNOTUM
SCHEMBL7748723 0.73 CYP1A2 (0.48) CHEK1CYP1A2CYP2A6EGFRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1427421-A1 2,4-DISUBSTITUTED PYRIMIDINYL DERIVATIVES FOR USE AS ANTICANCER AGENTS Amgen Inc. (US) 2004-06-16 EP disclosed
WO-2003018021-A1 2,4-DISUBSTITUTED PYRIMIDINYL DERIVATIVES FOR USE AS ANTICANCER AGENTS AMGEN INC. (US) 2003-03-06 WO disclosed